HUANG, FENGJIE

Release date:2016-05-13  Release:



HUANG, FENGJIE

Associate Professor of Microbiology & Biochemical Pharmacy

School of Life Science & Technology

Phone: 86-25-83271322

Email: hfj@cpu.edu.cn

Research Summary

Professor Huang’s research focuses on the separation and purification of natural products, the mechanism of medicine therapeutics, the diabetes-related pharmacology and the basic research on metabolism-regulation mechanism. She has rich practical experience on the research of fundamental medicine therapeuticsdisease animal model as the experimental subject. She also chairs and participates the projects supported by Hi-Tech research and development program of china (‘863’project) and National Natural Science Foundation of China for many times.

Education

2002-2005  Ph.D. Microbiology and Biochemical Pharmacy

China Pharmaceutical University (Nanjing) China


1999-2002  M.A. Fundamental Veterinary Science  

Huazhong Agricultural University (Wuhan) China

 

1995-1999  B.A. Animal Husbandry Science

Huazhong Agricultural University (Wuhan) China


Academic Experience

2011.9-      Associate professor, Department of Microbiology, School of Life Science and Technology, China Pharmaceutical University

2010.9-2011.9  Visiting Scientist, Keenan Research Centre for Biomedical Science, St. Michael’s Hospital

2005.6-2010.9Associate professor, Department of Microbiology, School of Life Science and Technology, China Pharmaceutical University

Awards and Honors

2010   Jiangsu blue project of excellent young teacher

2006the doctoral dissertation “Study on the purification, structure and effect of antibiabetes of active peptide S-8300 from shark liver” was selected to be the Excellent Doctoral Dissertation in Jiangsu Province


Publications

Books

HUANG Feng-Jie, WU Wu-Tong. Development and Market of Chinese Biopharmaceutical Industry. Progress in Pharmaceutical Science. 200630(4):185-191

Papers and Articles

1.Tian Qin1, Ronghui Du1, Fengjie Huang1, Shasha Yin, JunYang, Siyuan Qin, Wangsen Cao. Sinomenine activation of Nrf2 signaling prevents hyperactive inflammation and kidney injury in a mouse model of obstructive nephropathy. Free Radical Biology and Medicine.2016(92),90-99.(Co-first author)

2.Fang Zhao, Fengjie Huang, Mengxiong Tang, Xiaoming Li, Nina Zhang, Akis Amfilochiadis, Yiming Li, Renming Hu, Tianru Jin, Chun Peng and Qinghua Wang. Nodal induces apoptosis through activation of the ALK7 signaling pathway in pancreatic INS-1 b-cells. Am J Physiol Endocrinol Metab. 2012, 303: E132-E143. (Co-first author)

3.A. Maharaj & L. Zhu & F. Huang & H. Qiu & H. Li & C. Y. Zhang & T. Jin & Q. Wang. Ectopic expression of glucagon receptor in skeletal muscles improves glucose homeostasis in a mouse model of diabetes. Diabetologia,2002, 55:1458–1468.

4.FJ Huang, JX Ji, Jing Qian, KY Yang, Ying Zhang, YQ Xin, WT Wu. Isolation, characterization and biological activity of a novel peptide from sika (Cervus nippon Temminck) antler. Pharmaceutical Biotechnology, 201023(4):151-156

5.Huang F, Wu W. Purification and characterization of a new peptide (S-8300) from shark liver. J Food Biochem 2010; 34(5):962-970

6.HUANG Feng-jie, LV Li-li, QIAN Jing, WU Wu-tong*. Study on Cloning, Expressing and Bioactivity of S-8300’s cDNA Fragment. Chinese pharmaceutical Journal, 2010,452:93-97

7.HUANG Fengjie, WU Wutong. Study on the antidiabetic mechanism of a shark liver peptide S-8300 in alloxan-diabetes. Journal of Pharmacy and Pharmacology, 2009; 61: 789–794.